Toselli Richard M. 4
4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Nov 21, 2022
Insider Transaction Report
Form 4
Toselli Richard M.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-11-17+61,000→ 61,000 totalExercise: $2.50Exp: 2032-11-16→ Common Stock (61,000 underlying)
Footnotes (1)
- [F1]The option was granted on November 17, 2022. The shares underlying the option vest over two years, with 50% of the shares vesting on November 17, 2023 and the remaining shares vesting on November 17, 2024.